About Sanjivani Paranteral Ltd 
Sanjivani Paranteral Ltd
Micro Cap
Pharmaceuticals & Drugs
Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a public limited company in Oct.
Company Coordinates 
Company Details
205 P N Khotari Indl Estate, LBS Marg Bhandup (West) Mumbai Maharashtra : 400078
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital Structure 
Present Equity Capital
INR 11.68 Cr
Number of Shares
1.17 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
05-Feb-2024
1.17
11.68
1686000
10
Preferential Issue Of Shares
19-Aug-2021
99.98
10.00
1500000
10
Preferential basis
21-Jan-2021
84.98
8.50
2600000
10
Preferential basis
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Ashwani Khemka (25.9%)
Highest Public shareholder
Suresh Pukhraj Jain . (6.8%)
Individual Investors Holdings
54.08%
Management
Designation
Remuneration
Ashwin Khemka
Chairman & Managing Director
0
Mrunmai M Sarvankar
Independent Director
0
Shrenikkumar P Solanki
Independent Director
0
Monika Singhania
Independent Director
0
Srivardhan Ashwani Khemka
Director
0
Ritu Puglia
Company Sec. & Compli. Officer
0
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Jobwork
2.55
14.22%
Export Incentives
0.12
0.68%
Jobwork
Jobwork
Export Incentives
Export Incentives
Revenue and Profits:
Net Sales:
17 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2 Cr
Pharmaceuticals & Drugs
INR 280 Cr (Micro Cap)
38.00
33
0.00%
0.06
22.48%
8.53